Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

Therapeutic Potential of Myrrh and Ivermectin against Experimental Trichinella spiralis Infection in Mice

  • Basyoni, Maha M.A. (Department of Medical Parasitology, Faculty of Medicine, Cairo University) ;
  • El-Sabaa, Abdel-Aleem A. (Department of Histology, Faculty of Veterinary Medicine, Cairo University)
  • Received : 2013.02.26
  • Accepted : 2013.04.30
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Trichinosis is a parasitic zoonosis caused by the nematode Trichinella spiralis. Anthelmintics are used to eliminate intestinal adults as well as tissue-migrating and encysted larvae. This study aimed to investigate the effects of ivermectin and myrrh obtained from the aloe-gum resin of Commiphora molmol on experimental trichinosis. Ninety albino mice were orally infected with 300 T. spiralis larvae. Drugs were tested against adult worms at day 0 and day 5 and against encysted larvae on day 15 and day 35 post-infection (PI). Mature worms and encysted larvae were counted in addition to histopathological examination of muscle specimens. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), total protein, albumin, globulin, urea, and creatinine values were estimated. Significant reductions in mean worm numbers were detected in ivermectin treated mice at day 0 and day 5 PI achieving efficacies of 98.5% and 80.0%, while efficacies of myrrh in treated mice were 80.7% and 51.5%, respectively. At days 15 and 35 post-infection, ivermectin induced significant reduction in encysted larval counts achieving efficacies of 76.5% and 54.0%, respectively, while myrrh efficacies were 76.6% and 35.0%, respectively. AST, ALT, urea, and creatinine levels were reduced, while total proteins were increased in response to both treatments compared to their values in the infected non-treated mice. Ivermectin use for controlling T. spiralis could be continued. Myrrh was effective and could be a promising drug against the Egyptian strains of T. spiralis with results nearly comparable to ivermectin.

Keywords

References

  1. Murrell KD. Trichinellosis: now and forevermore? Parasite 2001; 8: S11-13. https://doi.org/10.1051/parasite/200108s2011
  2. Hosking BC, Watson TG, Leathwick DM. Multigeneric resistance to oxfendazole by nematodes in cattle. Vet Rev 1996; 138: 67-68. https://doi.org/10.1136/vr.138.3.67
  3. Teppema JS, Robinson JE, Ruitenberg EJ. Ultrastructural aspects of capsule formation in Trichinella spiralis infection in the rat. Parasitology 1973; 66: 291-296. https://doi.org/10.1017/S0031182000045224
  4. Cabié A, Bouchaud O, Houzé S, Khuong MA, Ruggeri C, Ancelle T, Matheron S, Coulaud JP. Albendazole versus thiabendazole as therapy for trichinosis: A retrospective study. Clin Infect Dis 1996; 22: 1033-1035. https://doi.org/10.1093/clinids/22.6.1033
  5. Campbell WC,Blair LS.Chemotherapy of Trichinella spiralis infections (a review). Exp Parasitol 1974; 35 : 304-334. https://doi.org/10.1016/0014-4894(74)90037-X
  6. Soliman GA, Taher ES, Mahmoud MA. Therapeutic efficacy of dormectin, ivermectin and levamisole against different stages of Trichinella spiralis in rats. Turkiye Parazitol Derg 2011; 35: 86-91. https://doi.org/10.5152/tpd.2011.22
  7. McCavera S, Walsh TK, Wolstenholme AJ. Nematode ligand-gated chloride channels: an appraisal of their involvement in macrocyclic lactone resistance and prospects for developing molecular markers. Parasitology 2007; 134: 1111-1121. https://doi.org/10.1017/S0031182007000042
  8. Chippaux JP, Boussinesg M, Prod'hon J. The use of ivermectin in control of onchocerciasis. Sante 1995; 5: 149-158.
  9. Kamel AM, El-Helal T, Hesham TM. Ivermectin and thiabendazole in experimental trichinosis. In Trichinellosis: Proceedings of the eighth international conference on trichinellosis. Italy. 1993, p 417.
  10. Ramisz A, Balicka-Laurans M, Grupiniski T. Efficacy of Moxidectin on experimental infection of Trichinella spiralis in mice. In Trichinellosis: Proceedings of the eighth international conference on trichinellosis. Italy. 1993, p 449-451.
  11. el-Azzouni MZ. Effect of ivermectin on experimental trichinosis. J Egypt Soc Parasitol 1997; 27: 331-340.
  12. Freedman DO, Zierdt WS, Lujan A, Nutman TB. The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans. J Infect Dis 1989; 159: 1151-1153. https://doi.org/10.1093/infdis/159.6.1151
  13. Abu El Ezz NM. Effects of Nigella sativa and Allium cepa oils on Trichinella spiralis in experimentally infected rats. J Egypt Soc Parasitol 2005; 35: 511-523.
  14. Atta AH, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol 1998; 60: 117-124. https://doi.org/10.1016/S0378-8741(97)00137-2
  15. Dolara P, Corte B, Ghelardini C, Pugliese AM, Cerbai E, Menichetti S, Lo Nostro A. Local anaesthetic and antifungal properties of sesquiterpenes from myrrh. Planta Med 2000; 66: 356-358. https://doi.org/10.1055/s-2000-8532
  16. Massoud A, Salama O, Bennett I. Therapeutic efficacy of new schistosmicidal drug derived from myrrh in active intestinal schistosomiasis complicated with hepatosplenomegaly. Proceedings of International Congress of Parasitology. 1998, p 24-28.
  17. El-Gohary Y, Massoud A, Kassem M, Abdo A, Hanno A, Salama O. Pilot study on a new fasciolicidal drug (Myrrh). Alex Med J 1999; 14: 12-27.
  18. Massoud AM, Fawzy SM, Salama OM. Laboratory studies on the molluscicidal and cercaricidal activities of Commiphora molmol. Egypt J Aquat Biol Fish 2000; 4: 251-266.
  19. Sheir Z, Nasr AA, Massoud A, Salama O, Badra GA, El-Shennawy H, Hassan N, Hammad SM. A safe, effective herbal anti-schistosomal therapy derived from myrrh. Am J Trop Med Hyg 2001; 65: 700-704. https://doi.org/10.4269/ajtmh.2001.65.700
  20. Guenther S, Nöckler K, von Nickisch-Rosenegk M, Landgraf M, Ewers C, Wieler LH, Schierack P. Detection of T. spiralis, T. britovi and T. pseudospiralis in muscle tissue with real-time PCR. J Microbiol Methods 2008; 75: 287-292. https://doi.org/10.1016/j.mimet.2008.06.019
  21. Coulaud JP, Lariviere M, Aziz MA, Gervais MC, Gaxotte P, Deluol AM, Cenac J. Ivermectin in onchocerciasis. Lancet 1984; 2: 526-527.
  22. Massoud A, Morsy TA, Haridy FM. Treatment of Egyptian dicrocoeliasis in man and animals with Mirazid. J Egypt Soc Parasitol 2003; 33: 437-442.
  23. Denham DA. Studies with methyridine and Trichinella spiralis. I. Effect upon the intestinal phase in mice. Exp Parasitol 1965; 17: 10-14. https://doi.org/10.1016/0014-4894(65)90003-2
  24. Carleton MA, Drury GA, Willington EA, Cammeron H. Carleton,s histological technique. 4th ed. New York, Toronto, London. Oxford Univ Press. 1967.
  25. Hosking BC, Watson TG, Leathwick DM. Multigeneric resistance to oxfendazole by nematodes in cattle. Vet Rec 1996; 138: 67-68. https://doi.org/10.1136/vr.138.3.67
  26. Gamble HR, Wisnewski N, Wasson DL. Diagnosis of trichinellosis in swine by enzyme immunoassay, using a synthetic glycan antigen. Am J Vet Res R 1997; 58: 1417-1421.
  27. Wu Z, Sofronic-Milosavljevic Lj, Nagano I, Takahashi Y. Trichinella spiralis: nurse cell formation with emphasis on analogy to muscle cell repair. Parasit Vectors 2008; 1: 27. https://doi.org/10.1186/1756-3305-1-27
  28. Gagliardo LF, McVay CS, Appleton JA. Molting, ecdysis, and reproduction of Trichinella spiralis are supported in-vitro by intestinal epithelial cells. Infect Immun 2002; 70: 1853-1859. https://doi.org/10.1128/IAI.70.4.1853-1859.2002
  29. Pozio E, Rinaldi L, Marucci G, Musella V, Galati F, Cringoli G, Boireau P, La Rosa G. Hosts and habitats of Trichinella spiralis and Trichinella britovi in Europe. Int J Parasitol 2009; 39: 71-79. https://doi.org/10.1016/j.ijpara.2008.06.006
  30. Gottstein B, Pozio E, Nöckler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev 2009; 22: 127-145. https://doi.org/10.1128/CMR.00026-08
  31. Kociecka W. Trichinellosis: human disease, diagnosis and treatment. Vet Parasitol 2000; 93: 365-383. https://doi.org/10.1016/S0304-4017(00)00352-6
  32. Siriyasatien P, Yingyourd P, Nuchprayoon S. Effects of albendazole against early and late stages of Trichinella spiralis infection in mice. J Med Assoc Thai 2003; 86: S257-262.
  33. Casulli A, Morales MA, Gallinella B, Turchetto L, Pozio E. 2-Hydroxypropyl-beta-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model. J Antimicrob Chemother 2006; 58: 886-890. https://doi.org/10.1093/jac/dkl329
  34. Despommier DD. Biology of Trichinella and trichinosis. In Campell WC ed, Trichinella and trichinosis. New York, USA. Plenum Press. 1983, p 42-75.
  35. Omar M, El Assaly T, Amer A, El Enbawy M. Effects of synanthic and ivomec on with reference to their serological evaluation. Vet Med J 1995; 43: 31-35.
  36. Song-Mingxin L, Yixin Zhang X, Hui H, Tian Yang L. Efficacy of ivermectin and albendazole against the various phases of 4 Trichinella isolates in treating mice. Chin J Zoon 2002; 18: 89-91.
  37. Barton NJ, Mitchell PJ, Hooke FG, Reynolds J. The therapeutic efficacy and prophylactic activity of dormectin against Dictyocaulus vivparus in cattles. Aust Vet J 1995; 72: 349-351. https://doi.org/10.1111/j.1751-0813.1995.tb07540.x
  38. Ros-Moreno RM, Moreno-Guzman MJ, Jimenez-Gonzalez A, Rodriguez-Caabeiro F. Interactions of ivermectin with gamma-aminobutyric acid receptors in Trichinella spiralis muscle larvae. Parasitol Res 1999; 85: 320-323. https://doi.org/10.1007/s004360050555
  39. Whealton A, Watson AJ, Rock RC. Colorimetric Determination of serum urea concentration. In Ashwood ER, Burtis CA, Tietz NW eds, Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia, USA. Saunders. 1994, p 1528-1531.
  40. Arise RO, Malomo SO. Effects of ivermectin and albendazole on some liver and kidney function indices in rats. Afr J Biochem Res 2009; 3: 190-197.
  41. Kimura I, Yoshikawa M, Kobayashi S, Sugihara Y, Suzuki M, Oominami H, Murakami T, Matsuda H, Doiphode VV. New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice. Bioorg Med Chem Lett 2001; 11: 985-989. https://doi.org/10.1016/S0960-894X(01)00111-1
  42. Al-Mathal EM. Efficacy of Commiphora molmol against hepatic coccidiosis (Eimeria stiedae) in the domestic rabbit. J Food Agric Environ 2010; 8: 1072-1080.
  43. Massoud A, El Sisi S, Salama O, Massoud A. Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). Am J Trop Med Hyg 2001; 65: 96- 99. https://doi.org/10.4269/ajtmh.2001.65.96
  44. Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminthes. Trends Parasitol 2004; 20: 469-476. https://doi.org/10.1016/j.pt.2004.07.010
  45. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 2007; 369: 2021-2029. https://doi.org/10.1016/S0140-6736(07)60942-8

Cited by

  1. Trichinella spiralis , potential model nematode for epigenetics and its implication in metazoan parasitism vol.4, pp.None, 2013, https://doi.org/10.3389/fphys.2013.00410
  2. Effect of myrrh and thyme on Trichinella spiralis enteral and parenteral phases with inducible nitric oxide expression in mice vol.110, pp.8, 2013, https://doi.org/10.1590/0074-02760150295
  3. Carbonic anhydrase enzyme as a potential therapeutic target for experimental trichinellosis vol.115, pp.6, 2013, https://doi.org/10.1007/s00436-016-4982-9
  4. Ein vortreffliches Geschenk der Erde: Ursprünge und Auswirkungen der Avermectine (Nobel‐Aufsatz) vol.128, pp.35, 2013, https://doi.org/10.1002/ange.201602164
  5. A Splendid Gift from the Earth: The Origins and Impact of the Avermectins (Nobel Lecture) vol.55, pp.35, 2013, https://doi.org/10.1002/anie.201602164
  6. Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations vol.70, pp.5, 2013, https://doi.org/10.1038/ja.2017.11
  7. Disruption of egg production by triclabendazole-resistant Fasciola hepatica following treatment with a commercial preparation of myrrh (Mirazid) vol.62, pp.2, 2017, https://doi.org/10.1515/ap-2017-0041
  8. Ultrastructural changes to the tegumental system and gastrodermal cells of adult Fasciola hepatica following treatment in vivo with a commercial preparation of myrrh (Mirazid) vol.91, pp.6, 2017, https://doi.org/10.1017/s0022149x16000705
  9. Microleakage of Aesthetic Restorations Following Functional Simulation and Immersion in Saudi-Traditional Mouth Rinses vol.7, pp.21, 2013, https://doi.org/10.3889/oamjms.2019.694
  10. Capsicum frutescens and Citrus limon: a new take on therapy against experimental trichinellosis vol.95, pp.None, 2013, https://doi.org/10.1017/s0022149x21000171
  11. Ivermectin, a potential anticancer drug derived from an antiparasitic drug vol.163, pp.None, 2013, https://doi.org/10.1016/j.phrs.2020.105207
  12. Therapeutic efficacy of mebendazole and artemisinin in different phases of trichinellosis: a comparative experimental study vol.148, pp.5, 2013, https://doi.org/10.1017/s0031182021000056